Midi Health
Overview
Midi Health is a cutting-edge virtual healthcare company based in Menlo Park, California, specializing in midlife health care for women, particularly focusing on perimenopause and menopause management. Founded in 2021 by Joanna Strober, Midi Health aims to provide personalized and accessible care to women experiencing hormonal changes. The company has rapidly scaled its operations, raising over $100 million through various funding rounds, with significant backing from influential investors, including Google Ventures and Emerson Collective.
Recent Developments
- October 2024: Midi Health continues to grow its market presence by expanding its clinical network, having already assembled 150 additional clinicians to cater to a growing patient base.
- September 2024: The company raised $5 million from a diverse set of 80 female investors, including celebrities like Amy Schumer and former Meta executives. This round follows their Series B funding of $63 million, showcasing robust investor confidence in Midi's mission to enhance menopause care access.
- August 2024: Midi Health partnered with Hinge Health to integrate movement-based therapies for women experiencing menopause-related musculoskeletal symptoms, offering a more comprehensive approach to care.
- April 2024: Secured $60 million in a Series B funding led by Emerson Collective, bringing the total raised to over $100 million. Funds will be used to expand nationwide insurance coverage and service lines.
- March 2024: Collaborated with Neurotrack to address cognitive impairments associated with menopause, providing tools for women to differentiate between menopause-induced brain fog and early dementia signs.
- 2023: Expanded its virtual clinic services to include all 50 U.S. states and partnered with major health systems like Memorial Hermann for broader access to care.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2021 |
| Headquarters | Menlo Park, California, USA |
| Founders | Joanna Strober |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Google Ventures (GV), Emerson Collective |
| Industry | Virtual Healthcare |
| Number of Employees | Over 200 healthcare providers |
Early History
Launched in 2021, Midi Health quickly identified a critical gap in healthcare for middle-aged women undergoing hormonal transitions. Founder Joanna Strober was driven by her personal experiences and frustrations with the healthcare system, which often overlooks menopause as a significant health concern requiring specialized care. Drawing on her professional background and insights, Midi Health was established to provide accessible, evidence-based care using a virtual model, which was particularly effective during the height of telehealth's adoption.
Company Profile and Achievements
Midi Health operates a virtual clinic network that provides comprehensive care plans addressing multiple symptoms of menopause. Their services include consultations with menopause-trained nurse practitioners, lifestyle coaching, and both hormonal and non-hormonal medical treatments.
- Funding Success: Midi raised $14 million in seed funding in 2022 and, later, completed both a $25 million Series A and a $60 million Series B.
- Market Expansion: The company has scaled its operations rapidly, increasing its network to serve a significant number of women across the United States.
- Strategic Partnerships: Collaborations with health systems like Memorial Hermann and businesses such as Hinge Health have bolstered their service offerings and reach.
Current Operations and Market Position
Midi Health is well-positioned in the rapidly growing femtech sector, providing virtual menopause care that is both insurance-covered and comprehensive. By expanding its insurance network and clinical expertise, the company is setting a benchmark in accessible women's healthcare for midlife challenges. Midi's focus on scalable, technology-driven solutions, combined with personalized care strategies, gives it a distinct competitive advantage in addressing complex health needs associated with menopause.
Conclusion
Midi Health has emerged as a significant player in the femtech space, addressing a historically underrepresented segment of female health care. With substantial funding and strategic collaborations, it has managed to innovate and expand its service offerings effectively. The company's future plans aim to reach a million women annually, breaking traditional barriers in menopause management and continuing to prioritize comprehensive, integrated care. This focus on scaling operations while maintaining high-quality service standards highlights Midi Health's potential to lead transformational changes in women's health globally.